11 /100
LOW RISK
Score updated May 29, 2026

PTGX — Protagonist Therapeutics, Inc. Dilution Risk Tracker

Track PTGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTGX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PTGX.
🔔 Track PTGX — Get forecast alerts →

💹 Market Data

Market Cap$6.46B
Shares Outstanding64.31M
Float52.49M
Cash$547.79M
Debt$9.78M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.3% shares (2025Q4 vs prior)
321 institutional holders · 80.17M shares
#1 FARALLON CAPITAL MANAGEMENT LLC 12.34M shares
#2 BlackRock, Inc. 9.72M shares
#3 VANGUARD GROUP INC 5.41M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.54M
Days to Cover11.9
% of Float14.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2016
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PTGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PTGX
📊 PTGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PTGX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.